MarketCap
Facebook
X
Telegram
Country |
 Cayman-islands |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.42 B |
Market Cap[1] |
$ 251 B |
EBITDA (LTM) |
$ 589 M |
P/E (LTM) |
- |
P/S (LTM) |
46.913027 |
EPS (LTM) |
0.2 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Brainstorm Cell Therapeutics
BCLI
|
- | -2.5 % | $ 5.88 M | Nasdaq Capital Market |  USA |
 |
Bio-Path Holdings
BPTH
|
- | - | $ 100 K | Nasdaq Capital Market | USA |
 |
Cara Therapeutics
CARA
|
- | -3.03 % | $ 260 M | Nasdaq Global Market,SPB | USA |
 |
ChromaDex Corporation
CDXC
|
- | -0.88 % | $ 598 M | Nasdaq Capital Market | USA |
 |
Caladrius Biosciences
CLBS
|
- | -16.75 % | $ 25.8 M | Nasdaq Capital Market | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
- | -5.98 % | $ 34.1 M | Nasdaq Capital Market | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
- | -4.36 % | $ 27 M | Nasdaq Capital Market | USA |
 |
Diffusion Pharmaceuticals
DFFN
|
- | 11.68 % | $ 8.97 M | Nasdaq Capital Market | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
- | -5.68 % | $ 8.28 M | Nasdaq Global Market | USA |
 |
Enochian Biosciences
ENOB
|
- | - | $ 40.5 M | Nasdaq Capital Market | USA |
 |
Esperion Therapeutics
ESPR
|
- | - | $ 661 M | Nasdaq Global Market,SPB | USA |
 |
Evofem Biosciences
EVFM
|
- | 7.55 % | $ 38.1 M | Nasdaq Capital Market | USA |
 |
Eyenovia
EYEN
|
- | 49.81 % | $ 13.2 M | Nasdaq Capital Market | USA |
 |
FibroGen
FGEN
|
- | - | $ 889 M | Nasdaq Global Select Market,SPB | USA |
 |
Homology Medicines
FIXX
|
- | 0.77 % | $ 53.4 M | Nasdaq Global Select Market | USA |
 |
Amicus Therapeutics
FOLD
|
- | - | $ 4.47 B | Nasdaq Global Market,SPB | USA |
 |
Frequency Therapeutics
FREQ
|
- | - | $ 528 M | Nasdaq Global Select Market | USA |
|
Galecto
GLTO
|
- | - | $ 762 M | Nasdaq Global Select Market |  Danmark |
 |
GlycoMimetics
GLYC
|
- | 9357.83 % | $ 1.01 B | Nasdaq Global Market | USA |
 |
Graybug Vision
GRAY
|
- | -11.23 % | $ 9.65 M | Nasdaq Global Market | USA |
|
Galera Therapeutics
GRTX
|
- | -32.59 % | $ 7.61 M | Nasdaq Global Market | USA |
 |
Happiness Biotech Group Limited
HAPP
|
- | 1.35 % | $ 17.8 M | Nasdaq Capital Market |  China |
 |
Hepion Pharmaceuticals
HEPA
|
- | -18.79 % | $ 39.3 K | Nasdaq Capital Market | USA |
 |
Hoth Therapeutics
HOTH
|
- | - | $ 18.8 M | Nasdaq Global Select Market | USA |
 |
IMARA
IMRA
|
- | 15.96 % | $ 663 M | Nasdaq Global Select Market | USA |
 |
KalVista Pharmaceuticals
KALV
|
- | - | $ 1.45 B | Nasdaq Global Select Market |  Britain |
 |
KemPharm
KMPH
|
- | -0.34 % | $ 200 M | Nasdaq Capital Market | USA |
 |
Kezar Life Sciences
KZR
|
- | - | $ 53.3 M | Nasdaq Global Select Market | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
- | - | $ 63.4 M | Nasdaq Capital Market | USA |
 |
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | USA |
 |
Magenta Therapeutics
MGTA
|
- | -7.74 % | $ 41.6 M | Nasdaq Global Select Market | USA |
 |
NovaBay Pharmaceuticals
NBY
|
- | - | $ 11.3 M | NYSE American | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
- | 0.43 % | $ 12 M | Nasdaq Global Select Market | USA |
 |
OncoCyte Corporation
OCX
|
- | 17.22 % | $ 355 K | NYSE American | USA |
 |
Onconova Therapeutics
ONTX
|
- | -0.47 % | $ 21 M | Nasdaq Capital Market | USA |
 |
Opthea Limited
OPT
|
- | - | $ 1.2 B | Nasdaq Global Select Market |  Australia |
|
BiomX
PHGE
|
$ 1.85 | 14.2 % | $ 3.02 M | NYSE American |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
- | -15.58 % | $ 1.22 B | Nasdaq Capital Market |  Germany |
 |
Plus Therapeutics
PSTV
|
- | - | $ 301 M | Nasdaq Capital Market | USA |
 |
Pluristem Therapeutics
PSTI
|
- | -1.9 % | $ 33.3 M | Nasdaq Global Select Market | Israel |
 |
Qualigen Therapeutics
QLGN
|
- | 5.59 % | $ 1.16 M | Nasdaq Global Select Market | USA |
|
Qilian International Holding Group Limited
QLI
|
- | -6.08 % | $ 184 M | Nasdaq Global Select Market | China |
 |
Cassava Sciences
SAVA
|
- | - | $ 110 M | Nasdaq Capital Market,SPB | USA |
 |
Selecta Biosciences
SELB
|
- | -8.69 % | $ 126 M | Nasdaq Global Market | USA |
 |
Sangamo Therapeutics
SGMO
|
- | - | $ 50.4 M | Nasdaq Global Select Market | USA |
 |
Salarius Pharmaceuticals
SLRX
|
- | - | $ 2.64 M | Nasdaq Global Select Market | USA |
 |
Sensei Biotherapeutics
SNSE
|
- | - | $ 17.5 M | Nasdaq Global Market | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
- | - | $ 826 K | Nasdaq Global Select Market | USA |
 |
Synthetic Biologics
SYN
|
- | 1.32 % | $ 16.2 M | NYSE American | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.